Loss of CD4

IFN-γ IL-10 Th1 immunity arginase 1 arginase 1 deficiency autoimmunity cell metabolism complement glutamine influenza infection

Journal

Immunity
ISSN: 1097-4180
Titre abrégé: Immunity
Pays: United States
ID NLM: 9432918

Informations de publication

Date de publication:
12 09 2023
Historique:
received: 14 10 2022
revised: 01 06 2023
accepted: 19 07 2023
medline: 15 9 2023
pubmed: 13 8 2023
entrez: 12 8 2023
Statut: ppublish

Résumé

Arginase 1 (Arg1), the enzyme catalyzing the conversion of arginine to ornithine, is a hallmark of IL-10-producing immunoregulatory M2 macrophages. However, its expression in T cells is disputed. Here, we demonstrate that induction of Arg1 expression is a key feature of lung CD4

Identifiants

pubmed: 37572656
pii: S1074-7613(23)00327-8
doi: 10.1016/j.immuni.2023.07.014
pmc: PMC10576612
mid: NIHMS1923920
pii:
doi:

Substances chimiques

Arginase EC 3.5.3.1
Glutamine 0RH81L854J
Arg1 protein, mouse EC 3.5.3.1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, N.I.H., Intramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

2036-2053.e12

Subventions

Organisme : NHLBI NIH HHS
ID : K22 HL125593
Pays : United States
Organisme : Intramural NIH HHS
ID : Z99 HL999999
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA DK075149
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA HL006223
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of interests M.S. is an inventor on a patent describing the use of RBD ligands for cell-surface evaluation of CAT1/solute carrier family 7 member 1 (SLC7A1) and other solute carrier (SLC) expression (N.T. gave up her rights); he is a co-founder and head of the scientific board of METAFORA-Biosystems, a start-up company that focuses on metabolite transporters under physiological and pathological conditions.

Références

J Immunol. 2002 May 15;168(10):4827-31
pubmed: 11994430
J Immunol. 2010 Aug 15;185(4):2182-90
pubmed: 20639484
Methods Enzymol. 2014;542:369-89
pubmed: 24862276
J Exp Med. 2004 Nov 15;200(10):1289-97
pubmed: 15534372
Amino Acids. 2014 May;46(5):1253-63
pubmed: 24515597
Immunity. 2020 Mar 17;52(3):513-527.e8
pubmed: 32187519
Semin Immunol. 2019 Aug;44:101344
pubmed: 31727465
Stem Cells. 2002;20(3):241-8
pubmed: 12004082
Antiviral Res. 2013 Sep;99(3):230-7
pubmed: 23721943
Biochemistry. 2013 Jun 4;52(22):3829-40
pubmed: 23442130
J Mol Med (Berl). 2015 Dec;93(12):1287-96
pubmed: 26467175
JCI Insight. 2019 Dec 19;4(24):
pubmed: 31852848
Cell. 2021 Aug 5;184(16):4186-4202.e20
pubmed: 34216540
Blood. 2001 Nov 15;98(10):3143-9
pubmed: 11698303
Nat Immunol. 2022 Jan;23(1):62-74
pubmed: 34764490
Cell. 2016 Oct 20;167(3):829-842.e13
pubmed: 27745970
Cell Mol Gastroenterol Hepatol. 2015 Mar 1;1(2):154-170
pubmed: 26000334
Metabolomics. 2007 Sep;3(3):211-221
pubmed: 24039616
Int J Mol Sci. 2020 Jul 25;21(15):
pubmed: 32722521
Nat Commun. 2021 Mar 5;12(1):1460
pubmed: 33674584
J Exp Med. 1994 Feb 1;179(2):589-600
pubmed: 7905019
Cell. 2018 Dec 13;175(7):1780-1795.e19
pubmed: 30392958
Immunity. 2018 Dec 18;49(6):1004-1019
pubmed: 30566879
J Immunol. 2011 Dec 1;187(11):5568-76
pubmed: 22043009
J Exp Med. 2001 Nov 19;194(10):1497-506
pubmed: 11714756
Nat Med. 2009 Mar;15(3):277-84
pubmed: 19234462
Nat Immunol. 2012 Dec;13(12):1213-21
pubmed: 23086448
Nucleic Acids Res. 2015 Apr 20;43(7):e47
pubmed: 25605792
Cell Mol Immunol. 2020 Sep;17(9):1010-1013
pubmed: 31974397
Int Rev Cell Mol Biol. 2018;341:125-168
pubmed: 30262031
Immunopharmacology. 1991 Mar-Apr;21(2):129-43
pubmed: 1831810
FEBS Lett. 1973 Feb 1;29(3):301-304
pubmed: 11946938
Immunity. 1994 Oct;1(7):553-62
pubmed: 7600284
Int J Cancer. 2021 Apr 15;148(8):1993-2009
pubmed: 33368291
J Immunol. 1996 Jul 15;157(2):798-805
pubmed: 8752931
J Virol. 2014 Aug;88(16):9010-6
pubmed: 24899187
Oncogene. 2019 Jun;38(24):4729-4738
pubmed: 30765862
Immunity. 2015 Jun 16;42(6):1033-47
pubmed: 26084023
Front Immunol. 2019 Oct 02;10:2351
pubmed: 31632414
Cell Immunol. 1987 May;106(2):420-7
pubmed: 3105898
Annu Rev Immunol. 2018 Apr 26;36:309-338
pubmed: 29677470
Cancer Lett. 2021 Apr 1;502:180-188
pubmed: 33450358
Crit Rev Immunol. 2012;32(6):463-88
pubmed: 23428224
Met Ions Biol Syst. 2000;37:407-28
pubmed: 10693141
JCI Insight. 2019 Nov 21;4(24):
pubmed: 31751318
Nat Commun. 2019 Jan 30;10(1):498
pubmed: 30700717
Trends Cancer. 2021 Aug;7(8):790-804
pubmed: 34020912
PLoS Pathog. 2010 Jun 17;6(6):e1000899
pubmed: 20585552
Cell Syst. 2015 Dec 23;1(6):417-425
pubmed: 26771021
Nat Med. 2006 Nov;12(11):1301-9
pubmed: 17041596
Bioinformatics. 2010 Jan 1;26(1):139-40
pubmed: 19910308
Nucleic Acids Res. 2019 May 7;47(8):e47
pubmed: 30783653
Mol Cell Biol. 2001 Feb;21(3):811-3
pubmed: 11154268
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
J Immunol. 2000 Feb 15;164(4):1839-46
pubmed: 10657632
Cell. 2013 Jun 6;153(6):1239-51
pubmed: 23746840
Front Immunol. 2014 Oct 27;5:533
pubmed: 25386179
Physiol Rev. 2018 Apr 1;98(2):641-665
pubmed: 29412048
J Exp Med. 2007 Feb 19;204(2):239-43
pubmed: 17296790
Sci Rep. 2018 Feb 27;8(1):3697
pubmed: 29487337
Sci Signal. 2015 Sep 29;8(396):ra97
pubmed: 26420908
J Infect Dis. 2018 Aug 24;218(7):1169-1174
pubmed: 29762692
Nat Immunol. 2008 Dec;9(12):1399-406
pubmed: 18978793
J Immunol. 1997 Mar 1;158(5):2259-67
pubmed: 9036973
Immunity. 2001 Nov;15(5):763-74
pubmed: 11728338
Curr Top Med Chem. 2018;18(6):432-443
pubmed: 29793408
Cancers (Basel). 2022 Jan 22;14(3):
pubmed: 35158820
J Immunol. 2008 Jul 15;181(2):891-8
pubmed: 18606640
Eur J Immunol. 1985 Aug;15(8):783-7
pubmed: 3875490
Exp Mol Med. 2020 Sep;52(9):1496-1516
pubmed: 32943735
Vaccine. 2017 Jul 24;35(33):4255-4261
pubmed: 28662951
J Immunol. 2009 Dec 15;183(12):7672-81
pubmed: 19933864
Immunity. 2011 Dec 23;35(6):871-82
pubmed: 22195744
Front Immunol. 2014 Jul 14;5:331
pubmed: 25071787
Nat Immunol. 2010 Sep;11(9):862-71
pubmed: 20694009
Mucosal Immunol. 2010 May;3(3):239-46
pubmed: 20200511
Eur J Immunol. 2016 Jan;46(1):92-103
pubmed: 26449889
Nat Biotechnol. 2016 Aug 9;34(8):794-5
pubmed: 27504761
Cell Rep. 2021 Nov 2;37(5):109911
pubmed: 34731632
Front Immunol. 2020 May 15;11:938
pubmed: 32499785

Auteurs

Erin E West (EE)

Complement and Inflammation Research Section (CIRS), National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA. Electronic address: erin.west@nih.gov.

Nicolas S Merle (NS)

Complement and Inflammation Research Section (CIRS), National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA.

Marcin M Kamiński (MM)

Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Gustavo Palacios (G)

Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Dhaneshwar Kumar (D)

Immunoregulation Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.

Luopin Wang (L)

Departments of Biochemistry and Computer Science, Purdue University, West Lafayette, IN, USA.

Jack A Bibby (JA)

Complement and Inflammation Research Section (CIRS), National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA.

Kirsten Overdahl (K)

Immunity, Inflammation, and Disease Laboratory, Division of Intramural Research, National Institute of Environmental Health Sciences (NIEHS), NIH, Research Triangle Park, NC, USA.

Alan K Jarmusch (AK)

Immunity, Inflammation, and Disease Laboratory, Division of Intramural Research, National Institute of Environmental Health Sciences (NIEHS), NIH, Research Triangle Park, NC, USA.

Simon Freeley (S)

School of Immunology and Microbial Sciences, King's College London, Guy's Hospital, Great Maze Pond, London SE1 9RT, UK.

Duck-Yeon Lee (DY)

Biochemistry Core, NHLBI, NIH, Bethesda, MD, USA.

J Will Thompson (JW)

Proteomics and Metabolomics Shared Resource, Center for Genomic and Computational Biology, Duke University, Durham, NC, USA.

Zu-Xi Yu (ZX)

Pathology Core, NHLBI, NIH, Bethesda, MD, USA.

Naomi Taylor (N)

Pediatric Oncology Branch, Rare Tumor Initiative, Center for Cancer Research, National Cancer Institute (NCI), NIH, Bethesda, MD, USA; Institut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier, CNRS, Montpellier, France.

Marc Sitbon (M)

Pediatric Oncology Branch, Rare Tumor Initiative, Center for Cancer Research, National Cancer Institute (NCI), NIH, Bethesda, MD, USA; Institut de Génétique Moléculaire de Montpellier (IGMM), Université de Montpellier, CNRS, Montpellier, France.

Douglas R Green (DR)

Department of Immunology, St. Jude Children's Research Hospital, Memphis, TN, USA.

Andrea Bohrer (A)

Inflammation and Innate Immunity Unit, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, USA.

Katrin D Mayer-Barber (KD)

Inflammation and Innate Immunity Unit, National Institute of Allergy and Infectious Diseases (NIAID), NIH, Bethesda, MD, USA.

Behdad Afzali (B)

Immunoregulation Section, Kidney Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), NIH, Bethesda, MD, USA.

Majid Kazemian (M)

Departments of Biochemistry and Computer Science, Purdue University, West Lafayette, IN, USA.

Sabine Scholl-Buergi (S)

Clinic for Pediatrics I, Inherited Metabolic Disorders, Medical University of Innsbruck, Innsbruck, Austria.

Daniela Karall (D)

Clinic for Pediatrics I, Inherited Metabolic Disorders, Medical University of Innsbruck, Innsbruck, Austria.

Martina Huemer (M)

Division of Metabolism and Children's Research Center, University Children's Hospital Zurich, University of Zurich, Zurich, Switzerland; Department of Pediatric Endocrinology and Diabetology, University Children's Hospital Basel, Basel, Switzerland; Department of Pediatrics, Landeskrankenhaus (LKH) Bregenz, Bregenz, Austria.

Claudia Kemper (C)

Complement and Inflammation Research Section (CIRS), National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), Bethesda, MD, USA. Electronic address: claudia.kemper@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH